Acuta Capital Partners, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Acuta Capital Partners, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $2.04 Million - $2.69 Million	-46,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $2 Million - $2.64 Million	46,000	46,000 $2.13 Million

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.